Trial intelligence / Profile preview

Effects of Propofol and Thiopental on Erythrocyte Nitric Oxide

NCT06485388Completed

Start
Mar 2024
Primary completion
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Trial of propofol and thiopental (2 arms). Primary endpoints: Erythrocyte Nitric Oxide Synthase Activity at 120 days and Erythrocyte-mediated Nitric Oxide Release at 120 days. Started Mar 2024; status: completed.

02

Drugs

propofolthiopental

Beyond the preview

Go deeper on NCT06485388.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06485388.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call